Dorsey & Whitney Trust’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-536
Closed -$227K 589
2021
Q3
$227K Sell
536
-62
-10% -$26.1K 0.02% 476
2021
Q2
$216K Buy
+598
New +$198K 0.02% 491

Other funds holding WST

Dorsey & Whitney Trust's WST Position: Q4 2021 in Review

Dorsey & Whitney Trust sold out of West Pharmaceutical (WST) in Q4 2021, closing a stake of 536 shares — an estimated $227K sold.

Dorsey & Whitney Trust first reported a position in WST in Q2 2021 and held it in 2 quarters. The position peaked at $227K in Q3 2021. 730 funds tracked by Wall St. Rank hold WST as of Q4 2021.

  • Dorsey & Whitney Trust reported no remaining West Pharmaceutical position as of Q4 2021 after selling out during the quarter.
  • Dorsey & Whitney Trust sold 536 West Pharmaceutical shares in Q4 2021, an estimated $227K.
  • Dorsey & Whitney Trust first reported a position in West Pharmaceutical in Q2 2021 and held it in 2 quarters.
  • Dorsey & Whitney Trust's West Pharmaceutical position peaked at $227K in Q3 2021.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2021.

Based on Dorsey & Whitney Trust's 13F filing for Q4 2021, filed 8 Feb 2022.